Address
Email address
Phone number
https://eastpharm.euNOVA-EastPharm OÜ - Your Experienced reliable partnerNOVA-EastPharm OÜ is an international pharmacetical company with more than 17 years of experience in CIS pharmaceutical markets.
Name
NOVA-EastPharm OÜ
Registry code
12859868
VAT number
EE101812100
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
02.06.2015 (9)
Financial year
01.01-31.12
Capital
25 500.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Olga Olyanishyna 16.07.1987 (37) | - | Person competent to receive procedural documents | - | Founder |
| Denis Priimägi 11.08.1975 (49) | - | Board member | - | |
| Ostap Kupnovytskyi 21.12.1968 (55) | - | Board member | - |
| 2019 13.01.2022 | 2020 04.04.2022 | 2021 21.10.2022 | 2022 20.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 8 710 000 € | 8 048 000 € | 11 114 000 € | 12 286 000 € |
| Net profit (loss) for the period | 1 082 000 € | - | - | - |
| Profit Margin | 12% | - | - | - |
| Current Assets | 3 616 000 € | - | - | - |
| Fixed Assets | 872 000 € | - | - | - |
| Total Assets | 4 488 000 € | 3 977 000 € | 6 508 000 € | 13 060 000 € |
| Current Liabilities | 3 203 000 € | - | - | - |
| Non Current Liabilities | 325 000 € | - | - | - |
| Total Liabilities | 3 528 000 € | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 960 000 € | - | - | - |
| Employees | 88 | 95 | 114 | 100 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 45 058.79 € | 239 620.84 € | 109 489.15 € | 3 |
| 2023 Q4 | - | 51 909.26 € | 52 915.01 € | 3 |
| 2023 Q3 | 50 983.97 € | 331 173.36 € | 56 566.05 € | 3 |
| 2023 Q2 | 7 366.8 € | 50 918.62 € | 51 124.7 € | 4 |
| 2023 Q1 | 48 014.63 € | 171 730.98 € | 61 693.64 € | 3 |
| 2022 Q4 | - | 204 039.46 € | 45 125.83 € | 2 |
| 2022 Q3 | - | 36 197.92 € | 23 810.58 € | 2 |
| 2022 Q2 | - | 11 537.76 € | 10 917.19 € | 2 |
| 2022 Q1 | - | 51 569.19 € | 11 362.44 € | 1 |
| 2021 Q4 | - | 2 858.4 € | 2 990.4 € | 1 |
| 2021 Q3 | - | 2 846.65 € | 3 038.4 € | 1 |
| 2021 Q2 | - | 2 846.4 € | 3 038.4 € | 1 |
| 2021 Q1 | - | 2 553.45 € | 2 733.51 € | 2 |
| 2020 Q4 | - | 2 846.4 € | 3 038.4 € | 2 |
| 2020 Q3 | - | 4 195.2 € | 4 451.2 € | 2 |
| 2020 Q2 | - | 4 296.47 € | 4 560.12 € | 2 |
| 2020 Q1 | - | 948.8 € | 1 012.8 € | 2 |
